热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　金斯瑞生物科技（01548）早盘上涨4.40%，现报12.34港元，成交额9190.05万港元。

　　交银国际发布报告称，看好金斯瑞生物科技（01548）估值修复的巨大空间，维持“买入”评级，给予目标价28.75港元。该行预计2025-26年公司非细胞业务收入增速将复苏至20%左右，同时传奇生物指引将在2026年实现扭亏为盈，进一步增厚利润。从净利润层面，2024年起集团将全面进入盈利区间，2024年净利润相较2023年将大幅增长。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.